Axsome Therapeutics (AXSM) Misses Q1 EPS by 93c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.03), $0.93 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22